Elisa Frullanti

4.1k total citations
49 papers, 805 citations indexed

About

Elisa Frullanti is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Elisa Frullanti has authored 49 papers receiving a total of 805 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 15 papers in Genetics and 13 papers in Cancer Research. Recurrent topics in Elisa Frullanti's work include RNA modifications and cancer (10 papers), Cancer Genomics and Diagnostics (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Elisa Frullanti is often cited by papers focused on RNA modifications and cancer (10 papers), Cancer Genomics and Diagnostics (7 papers) and Lung Cancer Treatments and Mutations (7 papers). Elisa Frullanti collaborates with scholars based in Italy, United States and France. Elisa Frullanti's co-authors include Alessandra Renieri, Tommaso A. Dragani, Felicia Stefania Falvella, Antonella Galvan, Ugo Pastorino, Francesca Mari, L. Santambrogio, Francesca Ariani, Margherita Baldassarri and Maria Palmieri and has published in prestigious journals such as SHILAP Revista de lepidopterología, JNCI Journal of the National Cancer Institute and Clinical Cancer Research.

In The Last Decade

Elisa Frullanti

45 papers receiving 794 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisa Frullanti Italy 17 504 154 142 105 103 49 805
Tianfu Li China 15 469 0.9× 138 0.9× 209 1.5× 109 1.0× 82 0.8× 44 853
Tarja Lamminen Finland 19 821 1.6× 184 1.2× 105 0.7× 123 1.2× 90 0.9× 35 1.3k
Nicolas Gadot France 20 520 1.0× 87 0.6× 108 0.8× 197 1.9× 54 0.5× 46 990
Xianghu Qu United States 15 916 1.8× 98 0.6× 148 1.0× 173 1.6× 95 0.9× 26 1.2k
Maya R. Vilà Spain 19 911 1.8× 167 1.1× 173 1.2× 223 2.1× 107 1.0× 31 1.3k
Wenwen Tang China 18 533 1.1× 47 0.3× 128 0.9× 125 1.2× 53 0.5× 40 967
Nikunj Sharma United States 12 963 1.9× 319 2.1× 178 1.3× 81 0.8× 78 0.8× 20 1.6k
Vincenzo Gigantino Italy 17 403 0.8× 130 0.8× 175 1.2× 165 1.6× 116 1.1× 30 922
Dustin S. Chang United States 5 557 1.1× 66 0.4× 137 1.0× 84 0.8× 40 0.4× 6 858
Tomoko Tsuchiya Japan 17 471 0.9× 85 0.6× 94 0.7× 162 1.5× 55 0.5× 34 882

Countries citing papers authored by Elisa Frullanti

Since Specialization
Citations

This map shows the geographic impact of Elisa Frullanti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Frullanti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Frullanti more than expected).

Fields of papers citing papers by Elisa Frullanti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Frullanti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Frullanti. The network helps show where Elisa Frullanti may publish in the future.

Co-authorship network of co-authors of Elisa Frullanti

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Frullanti. A scholar is included among the top collaborators of Elisa Frullanti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Frullanti. Elisa Frullanti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Noci, Sara, Tania Camboni, Eleonora Mangano, et al.. (2025). Regulatory polymorphisms of MSH6, MSH2, FBXO11, and PPP1R21 genes affect survival of patients with immunotherapy-treated lung cancer. Journal for ImmunoTherapy of Cancer. 13(9). e011526–e011526.
2.
Powrózek, Tomasz, et al.. (2025). Blood circulating miRNAs as pancreatic cancer biomarkers: An evidence from pooled analysis and bioinformatics study. International Journal of Biological Macromolecules. 308(Pt 4). 142469–142469.
3.
Markou, Athina, Tomasz Powrózek, Vera Constâncio, et al.. (2024). The Evidence Base for Circulating Tumor DNA-Methylation in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Cancers. 16(21). 3641–3641. 4 indexed citations
4.
Palmieri, Maria, et al.. (2024). The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions. Cancers. 16(16). 2882–2882. 3 indexed citations
5.
Palmieri, Maria & Elisa Frullanti. (2023). Different Liquid Biopsies for the Management of Non-Small Cell Lung Cancer in the Mutational Oncology Era. SHILAP Revista de lepidopterología. 11(1). 8–8. 8 indexed citations
6.
Monticelli, Maria, Bruno Hay Mele, Elisa Benetti, et al.. (2021). Protective Role of a TMPRSS2 Variant on Severe COVID-19 Outcome in Young Males and Elderly Women. Genes. 12(4). 596–596. 40 indexed citations
7.
Alaverdian, Diana, et al.. (2021). The Phenomenon of Multidrug Resistance in Glioblastomas. Hematology/Oncology and Stem Cell Therapy. 15(2). 1–7. 18 indexed citations
8.
Croci, Susanna, Miriam Lucia Carriero, Katia Capitani, et al.. (2020). AAV-mediated FOXG1 gene editing in human Rett primary cells. European Journal of Human Genetics. 28(10). 1446–1458. 13 indexed citations
9.
Croci, Susanna, Miriam Lucia Carriero, Katia Capitani, et al.. (2020). High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspot. European Journal of Human Genetics. 28(9). 1231–1242. 14 indexed citations
10.
Daga, Sergio, Francesco Donati, Katia Capitani, et al.. (2019). New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cells. European Journal of Human Genetics. 28(4). 480–490. 30 indexed citations
11.
Palmieri, Maria, Margherita Baldassarri, Francesca Fava, et al.. (2019). PIK3CA-CDKN2A clonal evolution in metastatic breast cancer and multiple points cell-free DNA analysis. Cancer Cell International. 19(1). 274–274. 1 indexed citations
12.
Pinto, Anna Maria, Eva Trevisson, Valeria Morbidoni, et al.. (2018). Parent-of-origin effect of hypomorphic pathogenic variants and somatic mosaicism impact on phenotypic expression of retinoblastoma. European Journal of Human Genetics. 26(7). 1026–1037. 16 indexed citations
13.
Mencarelli, Maria Antonietta, Chiara Fallerini, Laura Bianciardi, et al.. (2016). Potentially Treatable Disorder Diagnosed Post Mortem by Exome Analysis in a Boy with Respiratory Distress. International Journal of Molecular Sciences. 17(3). 306–306. 6 indexed citations
14.
Renieri, Alessandra, Maria Antonietta Mencarelli, Francesco Cetta, et al.. (2014). Oligogenic germline mutations identified in early non-smokers lung adenocarcinoma patients. Lung Cancer. 85(2). 168–174. 26 indexed citations
15.
Galván, Ana B., Elisa Frullanti, Giacomo Manenti, et al.. (2013). Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients. Carcinogenesis. 34(12). 2767–2773. 35 indexed citations
16.
Frullanti, Elisa, Carlo La Vecchia, Paolo Boffetta, & Carlo Zocchetti. (2012). Vinyl chloride exposure and cirrhosis: A systematic review and meta-analysis. Digestive and Liver Disease. 44(9). 775–779. 10 indexed citations
17.
Frullanti, Elisa, Carola Berking, Nadia Harbeck, et al.. (2011). Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor. European Journal of Cancer Prevention. 20(4). 340–347. 39 indexed citations
18.
Falvella, Felicia Stefania, Antonella Galvan, Elisa Frullanti, et al.. (2009). Transcription Deregulation at the 15q25 Locus in Association with Lung Adenocarcinoma Risk. Clinical Cancer Research. 15(5). 1837–1842. 63 indexed citations
19.
Falvella, Felicia Stefania, Elisa Frullanti, Antonella Galvan, et al.. (2009). FGFR4 Gly388Arg polymorphism may affect the clinical stage of patients with lung cancer by modulating the transcriptional profile of normal lung. International Journal of Cancer. 124(12). 2880–2885. 35 indexed citations
20.
Galvan, Antonella, Felicia Stefania Falvella, Monica Spinola, et al.. (2008). A polygenic model with common variants may predict lung adenocarcinoma risk in humans. International Journal of Cancer. 123(10). 2327–2330. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tianfu Li Breakdown of academic impact, for papers by Tarja Lamminen Breakdown of academic impact, for papers by Nicolas Gadot Breakdown of academic impact, for papers by Xianghu Qu Breakdown of academic impact, for papers by Maya R. Vilà Breakdown of academic impact, for papers by Wenwen Tang Breakdown of academic impact, for papers by Nikunj Sharma Breakdown of academic impact, for papers by Vincenzo Gigantino Breakdown of academic impact, for papers by Dustin S. Chang Breakdown of academic impact, for papers by Tomoko Tsuchiya
Rankless by CCL
2026